Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Osstem Implant Co., Ltd.
  6. News
  7. Summary
    A048260   KR7048260004

OSSTEM IMPLANT CO., LTD.

(A048260)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Osstem Implant Co., Ltd. announced that it expects to receive KRW 50 billion in funding from a group of investors

10/27/2020 EST

Osstem Implant Co., Ltd. (KOSDAQ:A048260) announced a private placement of series 7 unregistered non-guaranteed private convertible bonds for gross proceeds of KRW 50,000,000,000 on October 27, 2020. The transaction will include participation from Kb-Brain Kosdaq Scale-Up New Technology Business Investment Fund for KRW 8,000,000,000, Shinhan Investment Corp., Investment Arm for KRW 5,000,000,000, Hanyang Securities Co., Ltd., Investment Arm for KRW 4,000,000,000, Mirae Asset Capital Co,Ltd., Investment Arm for KRW 3,000,000,000, IBKC-EQP Innovative Technology Fund, a fund managed by Korea Investment Private Equity for KRW 2,000,000,000, Ibest Investment Company Ltd. for KRW 3,000,000,000, BNK Securities Co., Ltd., Investment Arm for KRW 1,000,000,000, Ace Investment & Finance Co., Ltd. for KRW 500,000,000, and SP Mezzanine Hedge Fund 6, SP KOSDAQ Venture Hedge Fund 2, Rhinos Mezzanine Private Investment Trust 6 and Anda H KOSDAQ Venture Hedge Fund A for KRW 2,000,000,000 each, Rhinos KOSDAQ Venture Public Offering Stock Private Investment Trust 3 and Solon New Technology Fund 1 for KRW 3,000,000,000 each, Rhinos Smart Korea Mezzanine Private Investment Trust for KRW 1,500,000,000, NH Absolute Return Hedge Fund 1, Rhinos Mezzanine Private Investment Trust 5, C Square Mezzanine Challenge and gratitude Hedge Fund 1 and Anda H KOSDAQ Venture Hedge Fund 1 for KRW 1,000,000,000 each, and Ace Susung New Technology Fund 10 and Rhinos KOSDAQ Venture Mezzanine Private Investment Trust 2 for 500,000,000 each. The bonds will be issued at par and do not carry any coupon. The bonds have yield to maturity of 0% and would mature on October 29, 2025. The bonds will be fully convertible into 1,290,788 shares representing 9.04% stake at a fixed conversion price of KRW 38,736 from October 29, 2022 to September 29, 2025. The subscription and the payment dates are October 29, 2020. The transaction has been approved by the board of directors of the company.


ę S&P Capital IQ 2020
All news about OSSTEM IMPLANT CO., LTD.
11/11Osstem Global Co., Ltd. announced that it expects to receive KRW 19.999584324 billion i..
CI
2020HansBiomed Corporation announced that it has received KRW 20 billion in funding from Os..
CI
2020HansBiomed Corporation announced that it expects to receive KRW 20 billion in funding f..
CI
2020Osstem Implant Co., Ltd. announced that it has received KRW 50 billion in funding from ..
CI
2020Osstem Implant Co., Ltd. announced that it expects to receive KRW 50 billion in funding..
CI
2020Osstem Implant Co., Ltd.'s Equity Buyback announced on August 21, 2019, has expired.
CI
2020Osstem Implant Co., Ltd.'s Equity Buyback Plan Shortened to February 11, 2020.
CI
2019Osstem Implant Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its..
CI
2019Osstem Implant Co., Ltd. authorizes a Buyback Plan.
CI
2019Osstem Implant Co Ltd to Invest USD 7.07 Million in POS-Austem Wuhan Automotive Co., Lt..
CI
More news
Financials
Sales 2021 816 B 0,68 B 0,68 B
Net income 2021 107 B 0,09 B 0,09 B
Net cash 2021 87,8 B 0,07 B 0,07 B
P/E ratio 2021 15,1x
Yield 2021 0,56%
Capitalization 1 533 B 1 281 M 1 284 M
EV / Sales 2021 1,77x
EV / Sales 2022 1,43x
Nbr of Employees 1 992
Free-Float 74,6%
Chart OSSTEM IMPLANT CO., LTD.
Duration : Period :
Osstem Implant Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OSSTEM IMPLANT CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 112 600,00 KRW
Average target price 172 550,00 KRW
Spread / Average Target 53,2%
EPS Revisions
Managers and Directors
Tae-Gwan Eom Chairman & Chief Executive Officer
Jeong-Wook Shin Independent Director
Joon-Seok Jeong Independent Director
Sung-Jo Hong Director, Senior MD & Head-Production
Doo-Won Kang Director, Senior Managing Director & Head-Sales
Sector and Competitors